Background Convalescent plasma has been widely used to treat COVID-19 and is under
investigation in numerous randomized clinical trials, but results are publicly available only …

The emergence of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected many countries throughout …

Convalescent plasma (CP) from patients recovered from COVID-19 is one of the most
studied anti-viral therapies against SARS-COV-2 infection. The aim of this study is to …

The COVID-19 pandemic has had a deep impact on people worldwide since late 2019 when
SARS-CoV-2 was first identified in Wuhan, China. In addition to its effect on public health, it …

The aim was to assess the clinical effectiveness of drugs used in hospitalized patients with
COVID-19 infection. We conducted a systematic review of randomized clinical trials …

Abstract Executive Summary Cardiothoracic surgical patients are at risk of increased
coronavirus disease severity. Several important factors influence the administration of the …

Background: Coronavirus disease 2019 (COVID-19), sweeping across the world, has
created a worldwide pandemic. Effective treatments of COVID-19 are extremely urgent …

Background Convalescent plasma treatment for severe and critically ill Corona Virus
Disease 2019 (COVID-19) patients remains controversial. Objective To evaluate the clinical …

Background: Coronavirus disease 2019 is a global public health concern. As of December
2020, the therapeutic agents approved for coronavirus disease 2019 in Japan were limited …

2. Materials and Methods The search was conducted in databases such as PubMod,
Scopus, ScienceDirect and Google Scholar on studies published from December 2019 to …